Preclinical Alzheimer's disease
Clinical trials for Preclinical Alzheimer's disease explained in plain language.
Never miss a new study
Get alerted when new Preclinical Alzheimer's disease trials appear
Sign up with your email to follow new studies for Preclinical Alzheimer's disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
A cholesterol drug takes on Alzheimer's before symptoms start
Disease control Not yet recruitingThis trial tests whether a daily pill called obicetrapib can slow early brain changes linked to Alzheimer's disease. Researchers will give the drug or a placebo to 400 adults who have signs of Alzheimer's-related proteins but no memory symptoms yet. The study measures changes in …
Matched conditions: PRECLINICAL ALZHEIMER'S DISEASE
Phase 2 • Sponsor: NewAmsterdam Pharma • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Alzheimer's vaccine aims to clear amyloid before memory fades
Prevention Not yet recruitingResearchers are testing an experimental vaccine called AV-1959R in adults aged 55 to 80 who have amyloid buildup in the brain but no memory or thinking problems. The trial compares the vaccine with a placebo to see whether it is safe, triggers an immune response, and lowers brain…
Matched conditions: PRECLINICAL ALZHEIMER'S DISEASE
Phase 2 • Sponsor: Institute for Molecular Medicine • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC